More SEC Filings
View Older Stories View Newer Stories-
Form DFAN14A NYLI CBRE Global Infrast Filed by: Saba Capital Management, L.P.
-
Form FWP HSBC USA INC /MD/ Filed by: HSBC USA INC /MD/
-
Form S-1/A Functional Brands Inc.
-
Form 8-K Senseonics Holdings, For: Sep 03
-
Form 424B3 GOLDMAN SACHS GROUP INC
-
Form 8-A12B Thrivent ETF Trust
-
Form 1-A/A Fortune Nickel & Gold
-
Form D ALLOCATE HOLDINGS INC.
-
Form D AM-0709 Fund I, a series
-
Form D AND VI, a series of FDVC
-
Form D TR-0509 Fund I, a series
-
Form 485BPOS Thrivent ETF Trust
-
Form 424B2 JPMORGAN CHASE & CO
-
Form S-4/A FLYEXCLUSIVE INC.
-
Form 424B2 UBS AG
-
Form FWP GOLDMAN SACHS GROUP INC Filed by: GOLDMAN SACHS GROUP INC
-
Form 424B3 UBS AG
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 BARCLAYS BANK PLC
-
Form 8-K FlexShopper, Inc. For: Aug 29
-
Form 424B2 CANADIAN IMPERIAL BANK
-
Form 6-K PETROBRAS - PETROLEO For: Sep 03
-
Form 424B5 HSBC HOLDINGS PLC
-
Form DEFA14A BGSF, INC.
-
Form 6-K CRESUD INC For: Sep 03
-
Form D HE-0721 Fund I, a series
-
Form D DCP 4364 LAWRENCE DRIVE,
-
Form 8-K MID AMERICA APARTMENT For: Sep 03
-
Form D/A Malika Master Fund I LP
-
Form D/A Provisio Medical Technol
-
Form 424B2 ROYAL BANK OF CANADA
-
Form D BA-0723 Fund I, a series
-
Form FWP GS Finance Corp. Filed by: GS Finance Corp.
-
Form D AR-0819 Fund I, a series
-
Form 10-Q PagerDuty, Inc. For: Jul 31
-
Form 6-K Inter & Co, Inc. For: Sep 03
-
Form D NOMO Ventures SPV T1,
-
Form C Bergamot Oil LLC
-
Form 424B2 Nomura America Finance,
-
Form FWP Petrobras Global Finance Filed by: PETROBRAS - PETROLEO BRASILEIRO SA
-
Form 425 M3-Brigade Acquisition Filed by: M3-Brigade Acquisition V Corp.
-
Form FWP HSBC USA INC /MD/ Filed by: HSBC USA INC /MD/
-
Form 424B5 FIRST CITIZENS BANCSHARE
-
Form FWP Petrobras Global Finance Filed by: PETROBRAS - PETROLEO BRASILEIRO SA
-
Form FWP HSBC USA INC /MD/ Filed by: HSBC USA INC /MD/
-
Form 497 Investment Managers Seri
-
Form N-CSRS Value Line Mid Cap Focus For: Jun 30
-
Form D Leon Private Wealth Fund
-
Form 8-K Atara Biotherapeutics, For: Sep 02


